TREA

86919081 - PASMAX

Follow

Information

  • Trademark
  • 86919081
  • Serial Number
    86919081
  • Registration Number
    5067522
  • Filing Date
    February 25, 2016
    8 years ago
  • Registration Date
    October 25, 2016
    8 years ago
  • Transaction Date
    June 13, 2023
    a year ago
  • Status Date
    May 05, 2023
    a year ago
  • Published for Opposition Date
    August 09, 2016
    8 years ago
  • Location Date
    October 25, 2016
    8 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HOLTZ, ALLISON A
  • Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
5000
Mark Identification
PASMAX
Case File Statements
  • DM0000: The mark consists of the letters "P a S m a x" with the letters "max" being superscript. The mark is black and white.
  • GS0051: Chemical reagents for medical or veterinary purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Cytostatics for pharmaceutical purposes; Drug delivery agents in the form of molecular solubility enhancer that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine
  • PM0001: PAS MAX
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Active chemical ingredients and solvents for use in the manufacture of insecticides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemicals for use in biotechnological product development; Chemicals for use in biotechnological manufacturing processes
  • GS0421: Chemical laboratories; Chemical research; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Research in the field of Antibody drug conjugates
Case File Event Statements
  • 5/5/2023 - a year ago
    25 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 10/25/2021 - 3 years ago
    24 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 10/25/2016 - 8 years ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/9/2016 - 8 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/9/2016 - 8 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/20/2016 - 8 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/2/2016 - 8 years ago
    19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 6/27/2016 - 8 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/25/2016 - 8 years ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/25/2016 - 8 years ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/22/2016 - 8 years ago
    15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/21/2016 - 8 years ago
    14 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/21/2016 - 8 years ago
    13 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/21/2016 - 8 years ago
    12 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/20/2016 - 8 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/20/2016 - 8 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/20/2016 - 8 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 6/13/2016 - 8 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/10/2016 - 8 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/10/2016 - 8 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/10/2016 - 8 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/10/2016 - 8 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/1/2016 - 8 years ago
    3 - NOTICE OF PSEUDO MARK E-MAILED Type: MPMK
  • 2/29/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/29/2016 - 8 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP